Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TNKS | O95271 | 1/20 | 0.34 |
| ▸ | TNKS2 | Q9H2K2 | 1/20 | 0.34 |
| ▸ | PDK2 | Q15119 | 2/20 | 0.33 |
| ▸ | PARP14 | Q460N5 | 1/20 | 0.32 |
| ▸ | MAP3K8 | P41279 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | MMP2 | P08253 | 4/20 | 0.31 |
| ▸ | MMP9 | P14780 | 4/20 | 0.31 |
| ▸ | MMP13 | P45452 | 4/20 | 0.31 |
| ▸ | MMP8 | P22894 | 2/20 | 0.31 |
| ▸ | PTGIR | P43119 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | RIPK2 | O43353 | 1/20 | 0.30 |
| ▸ | EGFR | P00533 | 1/20 | 0.30 |
| ▸ | KDR | P35968 | 1/20 | 0.30 |
| ▸ | TGFBR1 | P36897 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16802018 | 0.85 | PARP14 (0.43) | PDK2PARP14ALOX5PTGIRMAPT | |
| SCHEMBL30192444 | 0.85 | PARP14 (0.43) | PDK2PARP14ALOX5PTGIRMAPT | |
| SCHEMBL23372975 | 0.82 | MAPT (0.34) | PDK2MAP3K8PTGIRMAPT | |
| SCHEMBL22136342 | 0.82 | ALOX5 (0.43) | PDK2PARP14MAP3K8ALOX5 | |
| SCHEMBL22136344 | 0.81 | PTGIR (0.34) | PDK2MAP3K8PTGIRMAPTRIPK2 | |
| SCHEMBL24969722 | 0.81 | PARP14 (0.35) | TNKSTNKS2PARP14MAP3K8ALOX5 | |
| SCHEMBL19656537 | 0.81 | — | — | |
| SCHEMBL15138615 | 0.81 | PTGIR (0.44) | PDK2PARP14ALOX5MMP13PTGIR | |
| SCHEMBL23372498 | 0.81 | MAP3K8 (0.32) | PDK2MAP3K8ALOX5RIPK2EGFR | |
| SCHEMBL15714096 | 0.80 | PDK2 (0.38) | PDK2ALOX5MMP13PTGIRMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2021020799-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME ORGANIC ELECTRIC ELEMENT | 덕산네오룩스 주식회사 | 2021-02-04 | — | — | WO | disclosed |
| US-20210028370-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2021-01-28 | — | — | US | disclosed |
| EP-3466926-B1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO LTD (KR) | 2020-10-07 | — | — | EP | disclosed |
| WO-2020159135-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR | 덕산네오룩스 주식회사 | 2020-08-06 | — | — | WO | disclosed |
| WO-2019190101-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREFOR | 덕산네오룩스 주식회사 | 2019-10-03 | — | — | WO | disclosed |
| US-20190296244-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | DUK SAN NEOLUX CO., LTD. (KR) | 2019-09-26 | — | — | US | disclosed |
| WO-2019160335-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME, AND ELECTRONIC DEVICE THEREOF | 덕산네오룩스 주식회사 | 2019-08-22 | — | — | WO | disclosed |
| EP-3466926-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | Duk San Neolux Co., Ltd. (KR) | 2019-04-10 | — | — | EP | disclosed |
| WO-2017204557-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | 덕산네오룩스 주식회사 | 2017-11-30 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210028370-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREFOR | OR51E2, WEE1, SLC39A11 | TNKS 4125/4885TNKS2 4235/4885PDK2 1749/4885 |
| US-20190296244-A1 | COMPOUND FOR ORGANIC ELECTRONIC ELEMENT, ORGANIC ELECTRONIC ELEMENT USING SAME AND ELECTRONIC DEVICE THEREFOR | OR51E2, WEE2, WEE1 | TNKS 4626/4885TNKS2 4472/4885PDK2 1626/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.